MorphoSys Quote - MOR

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

17.87

Bid

17.90

Offer

18.11

Volume

53,518

17.80 Day's Range 18.20

0.00 52 Week Range 0.00

Market Cap

10.902B

Previous Close

18.18

Open

18.06

Last Trade

2255

17.87

Last Trade Time

Financial Volume

US$ 966,259

VWAP

18.0548

Average Volume (3m)

Shares Outstanding

150,620,548

Dividend Yield

PE Ratio

-57.46

Earnings Per Share (EPS)

-1.26

Revenue

238.28M

Net Profit

-189.73M

MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in di... MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.morphosys.com

Headquarters

Munich, Deu

Founded

1992

MorphoSys AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MOR. The last closing price for MorphoSys was US$18.18. Over the last year, MorphoSys shares have traded in a share price range of US$ 0.00 to US$ 0.00.

MorphoSys currently has 150,620,548 shares in issue. The market capitalisation of MorphoSys is US$10.90 billion. MorphoSys has a price to earnings ratio (PE ratio) of -57.46.

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CDXOACardieX Limited	AUD 0.025 (66.67%)	33.33k
SITSite Group International Ltd	AUD 0.003 (50.00%)	750k
PURPursuit Minerals Limited	AUD 0.0035 (40.00%)	3.29M
YARYari Minerals Ltd	AUD 0.004 (33.33%)	150k
LNRLanthanein Resources Ltd	AUD 0.004 (33.33%)	236.4k
LDROLode Resources Ltd	AUD 0.001 (-80.00%)	232.38k
EDEEden Innovations Ltd	AUD 0.001 (-50.00%)	116.92k
YPBYPB Group Ltd	AUD 0.002 (-33.33%)	2.59M
IBGOIronbark Zinc Limited	AUD 0.002 (-33.33%)	833.33k
SI6Si6 Metals Limited	AUD 0.002 (-33.33%)	540k
88E88 Energy Limited	AUD 0.0025 (25.00%)	88.61M
IBGIronbark Zinc Limited	AUD 0.003 (-25.00%)	12.61M
CLECyclone Metals Limited	AUD 0.001 (0.00%)	10M
MCTMetalicity Ltd	AUD 0.002 (-20.00%)	8.59M
IXRIonic Rare Earths Limited	AUD 0.011 (15.79%)	8.08M